References
- Zhang Y, Chapman AM, Plested M, et al. The incidence, prevalence, and mortality of stroke in France, Germany, Italy, Spain, the UK, and the US: a literature review. Stroke Res Treat. 2012;2012:3329668.
- Evers SM, Struijs JN, Ament AJ, et al. International comparison of stroke cost studies. Stroke. 2004;35:1209–1215.
- Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke. 2006;37:1179–1183.
- Hahne K, Monnig G, Samol A. Atrial fibrillation and silent stroke: links, risks, and challenges. Vasc Health Risk Manag. 2016;12:65–74.
- Weber-Kruger M, Gelbrich G, Stahrenberg R, et al. Finding atrial fibrillation in stroke patients: randomized evaluation of enhanced and prolonged Holter monitoring – Find-AF(RANDOMISED) – rationale and design. Am Heart J. 2014;168:438–445 e1.
- Kamel H, Smith WS. Detection of atrial fibrillation and secondary stroke prevention using telemetry and ambulatory cardiac monitoring. Curr Atheroscler Rep. 2011;13:338–343.
- Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.
- Deutsche Gesellschaft für Neurologie (DGN) [Internet]. S1-Leitlinie zur Diagnostik akuter zerebrovaskulärer Erkrankungen [S1 guideline for the diagnosis of acute cerebrovascular diseases]. 2012 [cited 2016 Oct 25]. Available from: https://www.dsg-info.de/images/stories/DSG/PDF/Leitlinien/LL_21_2012_diagnostik_akuter_zerebrovaskulaerer_erkrankungen.pdf.
- Stahrenberg R, Weber-Kruger M, Seegers J, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke. 2010;41:2884–2888.
- Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace. 2007;9:1006–1023.
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962.
- January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130:e199–267.
- European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–2429.
- Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–867.
- Baturova MA, Lindgren A, Carlson J, et al. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10 years after first-ever ischemic stroke. Int J Cardiol. 2017;232:134–139.
- Levin LA, Husberg M, Sobocinski PD, et al. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. Europace. 2015;17:207–214.
- Aronsson M, Svennberg E, Rosenqvist M, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace. 2015;17:1023–1029.
- Mayer F, Stahrenberg R, Groschel K, et al. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia. Clin Res Cardiol. 2013;102:875–884.
- Wachter R, Groschel K, Gelbrich G, et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol. 2017;16:282–290.
- Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Internet]. Allgmeine Methoden (Entwurf für Version 5.0 vom 07.12.2016) [General methods (draft for version 5.0 of 07.12.2016)]. 2016 [cited 2016 Apr 9]. Available from: https://www.iqwig.de/download/IQWiG_Methoden_Entwurf-fuer-Version-5_final.pdf.
- Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care. 2013;29:117–122.
- Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II – an ISPOR Good Research Practices Task Force report. Value Health. 2015;18:161–172.
- Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72.
- Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14:487–496.
- EuroQoL group. How to use EQ-5D 2016 [Internet] [cited 2016 Apr 23]. Available from: http://www.euroqol.org/about-eq-5d/how-to-use-eq-5d.html
- Hunger M, Sabariego C, Stollenwerk B, et al. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2012;21:1205–1216.
- Greiner W, Claes C, Busschbach JJ, et al. Validating the EQ-5D with time trade off for the German population. Eur J Health Econ. 2005;6:124–130.
- Bock JO, Brettschneider C, Seidl H, et al. Calculation of standardised unit costs from a societal perspective for health economic evaluation. Gesundheitswesen. 2015;77:53–61.
- Schwabe U, Paffrath D, Arzneiverordnungs-Report 2015. Aktuelle Daten, Kosten, Trends und Kommentare [Drug Prescription Report 2015. Current Data, Costs, Trends and Comments]. Berlin: Springer Berlin Heidelberg; 2015.
- Bundesministerium für Gesundheit (BMG). Pflegeleistungen ab Januar 2015 [Nursing services from January 2015] [Internet]. 2015 [cited 2016 Aug 9]. Available from: http://www.bmg.bund.de/fileadmin/dateien/Downloads/P/Pflegestaerkungsgesetze/Tabellen_Plegeleistungen_BRat_071114.pdf
- Statistisches Bundesamt [Internet]. Volkswirtschaftliche Gesamtberechnung. Fachserie 18, Reihe 1.4 [Economic total calculation. Subject series 18, series 1.4]. 2015 [cited 2016 Apr 23]. Available from: https://www.destatis.de/DE/Themen/Wirtschaft/Volkswirtschaftliche-Gesamtrechnungen-Inlandsprodukt/Publikationen/Downloads-Inlandsprodukt/inlandsprodukt-vorlaeufig-xlsx-2180140.xlsx?__blob=publicationFile.
- Bundesagentur für Arbeit. Statistik. Gemeldete Arbeitsstellen [Statistics. Registered jobs] [Internet]. 2016 [cited 2016 Apr 25]. Available from: https://statistik.arbeitsagentur.de/Navigation/Statistik/Statistik-nach-Themen/Arbeitslose-und-gemeldetes-Stellenangebot/Gemeldete-Stellen/Gemeldete-Arbeitsstellen-Nav.html
- Drummond M, McGuire A. Economic Evaluation in Health Care. Merging Theory with Practice. New York: Oxford University Press; 2001.
- Koopmanschap MA, Rutten FF, van Ineveld BM, et al. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14:171–189.
- van Asselt AD, van Mastrigt GA, Dirksen CD, et al. How to deal with cost differences at baseline. Pharmacoeconomics. 2009;27:519–528.
- Drummond M, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd ed. New York: Oxford University Press; 2005.
- van Eeden M, van Heugten C, van Mastrigt GA, et al. The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke. BMJ Open. 2015;5:e008220.
- Persson J, Ferraz-Nunes J, Karlberg I. Economic burden of stroke in a large county in Sweden. BMC Health Serv Res. 2012;12:341.
- Ciccone MM, Aquilino A, Cortese F, et al. Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo). Vasc Health Risk Manag. 2010;6:297–305.